Tegude Heike, Schnabel Anke, Zanger Ulrich M, Klein Kathrin, Eichelbaum Michel, Burk Oliver
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstrasse 112, D-70376 Stuttgart, Germany.
Drug Metab Dispos. 2007 Jun;35(6):946-54. doi: 10.1124/dmd.106.013565. Epub 2007 Mar 7.
Cytochrome P450 3A4 plays an outstanding role in the metabolism of clinically used drugs and shows a marked interindividual variability in expression even in the absence of inducing agents. Thus, regulation of basal expression contributes considerably to variability. The nuclear receptor hepatocyte nuclear factor 4alpha (HNF4alpha) was previously shown to be associated with basal hepatic CYP3A4 expression. As how HNF4alpha regulates basal expression of CYP3A4 still remains elusive, we systematically screened 12.5 kilobase pairs (kb) of the CYP3A4 5' upstream region for activation by the receptor in the human intestinal cell line LS174T. In this study, we newly identified two widely separated regions mediating the activation by HNF4alpha: a far distal region at -9.0 kb and the proximal promoter region at approximately -0.2 kb. By gel shift experiments and transient transfections, we characterized direct repeat (DR) 1-type motifs in both regions as functional HNF4alpha response elements. Cooperation of the two regions was shown to be required for maximal activation by HNF4alpha. The effect of HNF4alpha was antagonized by chicken ovalbumin upstream promoter transcription factor II, which was shown to bind to one of the DR1 motifs. Furthermore, activation of CYP3A4 via the DR1 element in the proximal promoter depends on an additional, yet unknown, factor, which is binding at approximately -189 base pairs. Physiological relevance of this position for activation by HNF4alpha in vivo is suggested by the presence of a binding activity in small intestine similar to that in LS174T cells. In summary, we here have elucidated a molecular mechanism of direct regulation of CYP3A4 by HNF4alpha, which is probably specific for the intestine.
细胞色素P450 3A4在临床用药代谢中发挥着重要作用,即使在没有诱导剂的情况下,其表达也存在显著的个体间差异。因此,基础表达的调控在很大程度上导致了这种差异。此前研究表明,核受体肝细胞核因子4α(HNF4α)与肝脏中CYP3A4的基础表达相关。由于HNF4α如何调控CYP3A4的基础表达仍不清楚,我们系统地筛选了CYP3A4 5'上游区域12.5千碱基对(kb),以研究其在人肠细胞系LS174T中被该受体激活的情况。在本研究中,我们新鉴定出两个相距甚远的区域介导HNF4α的激活作用:一个位于-9.0 kb的远上游区域和一个位于约-0.2 kb的近端启动子区域。通过凝胶迁移实验和瞬时转染,我们将这两个区域中的直接重复(DR)1型基序鉴定为功能性HNF4α反应元件。结果表明,HNF4α要实现最大程度的激活,这两个区域需要协同作用。鸡卵清蛋白上游启动子转录因子II可拮抗HNF4α的作用,该转录因子可与其中一个DR1基序结合。此外,近端启动子中通过DR1元件对CYP3A4的激活作用还依赖于另一个未知因子,该因子结合在约-189碱基对处。小肠中存在与LS174T细胞中类似的结合活性,提示该位置在体内对HNF4α激活作用具有生理相关性。总之,我们在此阐明了HNF4α直接调控CYP3A4的分子机制,这一机制可能在肠道中具有特异性。